NCT05246709

Brief Summary

This study will evaluate whether applying micro drops of cyanoacrylate glue to the participant's peripherally inserted central catheter (PICC) insertion site prior to covering the area of PICC line with a transparent film dressing will make the PICC dressing last longer and prevent an occurrence of PICC line moving out of its original placement. The investigators aims to evaluate whether 1) using the cyanoacrylate glue will lengthen the time to first dressing change; and 2) participants in the experimental arm (glue used) will have fewer dressing changes per week compared to the control arm (standard care) during admission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 18, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

February 26, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2022

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

June 26, 2025

Completed
Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

February 9, 2022

Results QC Date

January 27, 2025

Last Update Submit

June 25, 2025

Conditions

Keywords

PICC line dressingcyanoacrylate glueNICU

Outcome Measures

Primary Outcomes (1)

  • Duration of Longevity of PICC Line Dressing

    Duration of longevity defined as the number of days the PICC line dressing lasts from the scheduled dressing change.

    Up to 7 days

Secondary Outcomes (1)

  • Number of PICC Line Migrations

    Until PICC line removal (approximately 12 weeks)

Study Arms (2)

Control Group

ACTIVE COMPARATOR

This group will be received the current standard of care (SOC) dressing method for PICC lines.

Device: Standard transparent film dressing

Cyanoacrylate Glue Group

EXPERIMENTAL

This group will receive a few drops of cyanoacrylate glue on PICC line site prior to application of usual standard film dressing over the PICC line site.

Device: Cyanoacrylate glueDevice: Standard transparent film dressing

Interventions

Adhesive to be applied on the PICC line site prior to usual standard film dressing over the site, such as SecurePortIV® Catheter Securement Adhesive by Adhezion Biomedical® Cyanoacrylate adhesive that is FDA-approved for securement of vascular access devices. Securement method that provides microbial protection by sealing the insertion site.

Also known as: SecurePortIV® Catheter Securement Adhesive
Cyanoacrylate Glue Group

A standard transparent polyurethane film dressing, such as 3M TEGADERM Film, for dressing the PICC line area.

Control GroupCyanoacrylate Glue Group

Eligibility Criteria

Age1 Day - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All patients admitted to the 9 North intensive coronary care unit (ICCU) at NewYork-Presbyterian Morgan Stanley Children's Hospital greater than 35 weeks of corrected gestational age who have a PICC line placed by a NICU provider.

You may not qualify if:

  • Any patient with a PICC line in situ from an outside hospital.
  • Any patient with a PICC line placed by an outside department, namely the interventional radiology department.
  • Any patient with a PICC line that is silicon material catheter, such as Vygon Epicutaneo-Cava catheter because of limited accuracy of measuring a movement of the catheter migration after 25 centimeter mark due to absence of a centimeter mark on the catheter.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NewYork-Presbyterian Morgan Stanley Children's Hospital at CUIMC

New York, New York, 10032, United States

Location

Related Publications (7)

  • Acun C, Baker A, Brown LS, Iglesia KA, Sisman J. Peripherally inserted central cathether migration in neonates: Incidence, timing and risk factors. J Neonatal Perinatal Med. 2021;14(3):411-417. doi: 10.3233/NPM-200684.

    PMID: 33459671BACKGROUND
  • Bierlaire S, Danhaive O, Carkeek K, Piersigilli F. How to minimize central line-associated bloodstream infections in a neonatal intensive care unit: a quality improvement intervention based on a retrospective analysis and the adoption of an evidence-based bundle. Eur J Pediatr. 2021 Feb;180(2):449-460. doi: 10.1007/s00431-020-03844-9. Epub 2020 Oct 20.

    PMID: 33083900BACKGROUND
  • D'Andrea V, Pezza L, Barone G, Pronterà G, Pittiruti M, Vento G. Comparison study: before/after the practice change of the use of medical cyanoacrylate glue for securing ECC (epicutaneo-caval catheter). The Journal of Vascular Access. 2021; 00(0). 1-4.

    BACKGROUND
  • Guido A, Zhang S, Yang C, Pook L. An innovative cyanoacrylate device developed to improve the current standard of care for intravascular catheter securement. J Vasc Access. 2020 May;21(3):293-299. doi: 10.1177/1129729819872881. Epub 2019 Sep 9.

    PMID: 31495268BACKGROUND
  • Kleidon TM, Ullman AJ, Gibson V, Chaseling B, Schoutrop J, Mihala G, Rickard CM. A Pilot Randomized Controlled Trial of Novel Dressing and Securement Techniques in 101 Pediatric Patients. J Vasc Interv Radiol. 2017 Nov;28(11):1548-1556.e1. doi: 10.1016/j.jvir.2017.07.012. Epub 2017 Sep 19.

    PMID: 28893464BACKGROUND
  • Ostroff M, Zauk A, Chowdhury S, Moureau N, Mobley C. A retrospective analysis of the clinical effectiveness of subcutaneously tunneled femoral vein cannulations at the bedside: A low risk central venous access approach in the neonatal intensive care unit. J Vasc Access. 2021 Nov;22(6):926-934. doi: 10.1177/1129729820969291. Epub 2020 Nov 5.

    PMID: 33148114BACKGROUND
  • Sharpe E, Kuhn L, Ratz D, Krein SL, Chopra V. Neonatal Peripherally Inserted Central Catheter Practices and Providers: Results From the Neonatal PICC1 Survey. Adv Neonatal Care. 2017 Jun;17(3):209-221. doi: 10.1097/ANC.0000000000000376.

    PMID: 28045704BACKGROUND

MeSH Terms

Conditions

Infant, Newborn, Diseases

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Seon Mi Jeong
Organization
Columbia University

Study Officials

  • Marianne Garland, MD

    Morgan Stanley Children's Hospital of NYP

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized control study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Pediatrics

Study Record Dates

First Submitted

February 9, 2022

First Posted

February 18, 2022

Study Start

February 26, 2022

Primary Completion

September 15, 2022

Study Completion

November 16, 2022

Last Updated

June 26, 2025

Results First Posted

June 26, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Plan to submit the study finding to professional nursing journals, such as Advanced in Neonatal Care, Journal of Neonatal Nursing, and etc

Shared Documents
CSR
Time Frame
1 to 2 years
Access Criteria
To be determined by the PI

Locations